Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial.

Eur Urol

University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address:

Published: June 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2024.05.025	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649856	PMC

Publication Analysis

docetaxel carboplatin

carboplatin treatment

treatment patients

patients metastatic

metastatic castration-resistant

castration-resistant prostate

prostate cancer

cancer biallelic

biallelic inactivation

inactivation genes

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!